# Multi-strain Probiotic in the Management of IBS-D

> **NCT03251625** · PHASE4 · COMPLETED · sponsor: **Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh** · enrollment: 400 (actual)

## Conditions studied

- Irritable Bowel Syndrome

## Interventions

- **DRUG:** Probiotic Formula Capsule

## Key facts

- **NCT ID:** NCT03251625
- **Lead sponsor:** Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2016-04
- **Final completion:** 2016-04
- **Target enrollment:** 400 (ACTUAL)
- **Last updated:** 2018-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03251625

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03251625, "Multi-strain Probiotic in the Management of IBS-D". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT03251625. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*